D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables (Q34562562)

From Wikidata

Revision as of 09:49, 8 January 2019 by QuickStatementsBot (talk | contribs) (‎Removed claim: author name string (P2093): Lindsey B DeBoer, #quickstatements; #temporary_batch_1546929243722; invoked by sourcemd_batch_processing on behalf of User:GerardM (batch 5275))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Jasper A J Smits

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Stefan G Hofmann

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

David Rosenfield

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Paul T Costa

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Naomi M Simon

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Conall O'Cleirigh

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Alicia E Meuret

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Luana Marques

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Michael W Otto

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Mark H Pollack

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

12 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Journal of Consulting and Clinical Psychology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

81

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1100-1112

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Outcomes of acute phase cognitive therapy in outpatients with anxious versus nonanxious depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Predictors of response to an attention modification program in generalized social phobia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

The role of adherence in the relationship between conscientiousness and perceived health

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

The influence of personality traits on reported adherence to medication in individuals with chronic disease: an epidemiological study in West Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Cognitive enhancers for anxiety disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

A genetic variant BDNF polymorphism alters extinction learning in both mouse and human

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Cognitive factors that maintain social anxiety disorder: a comprehensive model and its treatment implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Effects of D-cycloserine on extinction: translation from preclinical to clinical work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

The promise of extinction research for the prevention and treatment of anxiety disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Cognitive-behavioral therapy for the treatment of anxiety disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Mediators and moderators of treatment effects in randomized clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Psychotherapy research with ethnic minorities: empirical, ethical, and conceptual issues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

An exploratory study of ethnicity and psychotherapy outcome among HIV-positive patients with depressive symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Social phobia. Comorbidity and morbidity in an epidemiologic sample

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

7 July 2018

Cognitive behavioural group therapy for social phobia: evidence of transportability to community clinics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

27 October 2018

Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

27 October 2018

The role of personality in psychotherapy for anxiety and depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

27 October 2018

A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

27 October 2018

Impact of depressive symptoms on the treatment of generalized social anxiety disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

27 October 2018

Treating depression in predominantly low-income young minority women: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241751

27 October 2018

Identifiers

10.1037/A0034120

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34562562&oldid=830131132"